文献速递脑血管病

轻型卒中溶栓治疗的预测因素:佛罗里达-波多黎各减少卒中差异合作研究

Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities.
PubMed 文献 · Stroke · 2018-02-19

该研究基于FL-PR CReSD登记研究,纳入2010年1月至2015年4月期间症状出现4小时内到院的7746例持续神经症状且NIHSS≤5的缺血性卒中或TIA患者,最终分析6826例无溶栓禁忌者。多因素分析显示,早期到院、较高NIHSS评分、就诊时失语、较快door-to-CT时间及就诊于学术医院是溶栓治疗的独立预测因素。

要点

  • 轻型卒中患者溶栓率为18.7%(1281/6826)。
  • 0-2小时到院者溶栓OR为8.16(95%CI 4.76-13.98),高于≥3.5小时到院者。
  • NIHSS每增加1分,溶栓OR为1.87(95%CI 1.77-1.98)。

核心结论

  • 轻型急性卒中患者若年轻、白人或西班牙裔、早期到院且神经功能缺损较重,则更可能接受溶栓治疗。

研究设计与样本

  • 前瞻性队列研究,纳入FL-PR CReSD登记研究中2010年1月至2015年4月期间最终诊断为缺血性卒中或TIA的患者73 712例,筛选出持续神经症状且NIHSS≤5、症状出现4小时内到院的7746例,最终分析无溶栓禁忌的6826例。

主要发现

  • 溶栓组(n=1281,18.7%)较未溶栓组更年轻(68岁 vs 72岁),高血压、糖尿病、血脂异常等血管危险因素更少,既往心肌梗死、外周血管病、卒中史风险更低,就诊中位NIHSS更高(4 vs 2)。
  • 多因素模型中,0-2小时到院 vs ≥3.5小时到院的OR为8.16(95%CI 4.76-13.98)。
  • NIHSS评分OR为1.87(95%CI 1.77-1.98);就诊时失语OR为1.35(95%CI 1.12-1.62)。
  • door-to-CT时间较快OR为1.81(95%CI 1.53-2.15);就诊于学术医院OR为2.02(95%CI 1.39-2.95)。

关键数值与推荐

  • 轻型卒中定义为持续神经症状且NIHSS≤5;纳入分析者为无溶栓禁忌者。
  • 溶栓治疗的独立预测因素包括:0-2小时到院(OR 8.16,95%CI 4.76-13.98)、较高NIHSS(OR 1.87,95%CI 1.77-1.98)、就诊时失语(OR 1.35,95%CI 1.12-1.62)、较快door-to-CT时间(OR 1.81,95%CI 1.53-2.15)、学术医院就诊(OR 2.02,95%CI 1.39-2.95)。

临床怎么用

  • 原文未据此给出推荐;作者指出识别溶栓预测因素对未来设计评估轻型卒中溶栓应用的研究很重要。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND PURPOSE: Mild stroke is the most common cause for thrombolysis exclusion in patients acutely presenting to the hospital. Thrombolysis administration in this subgroup is highly variable among different clinicians and institutions. We aim to study the predictors of thrombolysis in patients with mild ischemic stroke in the FL-PR CReSD registry (Florida-Puerto Rico Collaboration to Reduce Stroke Disparities). METHODS: Among 73 712 prospectively enrolled patients with a final diagnosis of ischemic stroke or TIA from January 2010 to April 2015, we identified 7746 cases with persistent neurological symptoms and National Institutes of Health Stroke Scale ≤5 who arrived within 4 hours of symptom onset. Multilevel logistic regression analysis with generalized estimating equations was used to identify independent predictors of thrombolytic administration in the subgroup of patients without contraindications to thrombolysis. RESULTS: We included 6826 cases (final diagnosis mild stroke, 74.6% and TIA, 25.4%). Median age was 72 (interquartile range, 21); 52.7% men, 70.3% white, 12.9% black, 16.8% Hispanic; and median National Institutes of Health Stroke Scale, 2 (interquartile range, 3). Patients who received thrombolysis (n=1281, 18.7%) were younger (68 versus 72 years), had less vascular risk factors (hypertension, diabetes mellitus, and dyslipidemia), had lower risk of prior vascular disease (myocardial infarction, peripheral vascular disease, and previous stroke), and had a higher presenting median National Institutes of Health Stroke Scale (4 versus 2). In the multilevel multivariable model, early hospital arrival (arrive by 0-2 hours versus ≥3.5 hours; odds ratio [OR], 8.16; 95% confidence interval [CI], 4.76-13.98), higher National Institutes of Health Stroke Scale (OR, 1.87; 95% CI, 1.77-1.98), aphasia at presentation (OR, 1.35; 95% CI, 1.12-1.62), faster door-to-computed tomography time (OR, 1.81; 95% CI, 1.53-2.15), and presenting to an academic hospital (OR, 2.02; 95% CI, 1.39-2.95) were independent predictors of thrombolysis administration. CONCLUSIONS: Mild acutely presenting stroke patients are more likely to receive thrombolysis if they are young, white, or Hispanic and arrive early to the hospital with more severe neurological presentation. Identification of predictors of thrombolysis is important in design of future studies to assess the use of thrombolysis for mild stroke.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Asdaghi N, Wang K, Ciliberti-Vargas MA, et al. Predictors of Thrombolysis Administration in Mild Stroke: Florida-Puerto Rico Collaboration to Reduce Stroke Disparities. Stroke. 2018. PMID: 29459397. doi:10.1161/STROKEAHA.117.019341

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。